Diabetic gastroparesis is a condition that causes frequent nausea and vomiting, which has a negative impact on quality of life and poses a significant burden on the healthcare system. Metoclopramide is a dopamine antagonist used to treat nausea and vomiting that may be associated with diabetic gastroparesis in addition to gastroesophageal reflux disease (GER...
Metoclopramide in the oral tablet form is used for symptomatic treatment of both acute and recurrent diabetic gastroparesis, in addition to the treatment of gastroesophageal reflux disease (GERD) in patients who have failed to respond to traditional therapy. A nasal spray formulation is also indicated to treat adults with acute, recurrent diabetic gastropare...
Abteilung Klinische Pharmakologie, UKT Tübingen, Tübingen, BW, Germany
Montefiore Medical Center, Bronx, New York, United States
Duke University Medical Center, Durham, North Carolina, United States
Örebro University Hospital, Örebro, Sweden
Martin-Luther-University Halle-Wittenberg, Department for Oncology and Hematology, Ernst-Grube-Strasse 40, Halle (Saale), Sachsen-Anhalt, Germany
Division of medical oncology, department of medicine Siriraj Hospital, Bangkok, Thailand
Montefiore Medical Center, Bronx, New York, United States
Impact Clinical Trials, Los Angeles, California, United States
Theda Oaks Endoscopy Center, San Antonio, Texas, United States
Consultants for Clinical Research, Cincinnati, Ohio, United States
York Hospital, York, Pennsylvania, United States
Montefiore Medical Center, Bronx, New York, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.